ABSTRACT BACKGROUND: Recent fi ndings showed that activated TLR signals on cancer cells might promote cancer progression. This study was designed to explore the infl uence of Toll-like receptor 4 (TLR4) agonist lipopolysaccharides (LPS) on mouse melanoma and breast cancer cell proliferation and their TLR4 signalling. METHODS: Mouse melanoma cell line (B16F10) and breast cancer cell line (4T1) were taken as models. They were treated with LPS (0, 1.25, 2.5, 5, 7.5, 10 μg/ml) for 4, 16, 24, 48 h and MTT assay was done. The expression of TLR4, MyD88, NF-κB mRNA was detected by quantitative real time-polymerase chain reaction method quantitatively. RESULTS: Ultra-pure LPS at 5 μg/ml concentration increased signifi cantly B16F10 cell viability 24 hour after stimulation, but not in 4T1 cell. The mRNA levels of TLR4, MyD88 and NF-κB were signifi cantly up-regulated in both cell lines by stimulating the cells at 5 μg/ml LPS. CONCLUSIONS: Our data demonstrated that B16F10 and 4T1 cells are responsive to LPS, but their responses are time and dose dependent. These results provide new ways to understand the TLR4 signalling in tumour cells (Fig. 2, Ref. 24) . Text in PDF www.elis.sk.
Introduction
Toll-like receptors (TLRs) are the class of proteins (1) that recognize microbial/pathogen-associated molecular patterns (2) . Given the ability of TLRs to recognize a large number of pathogenassociated ligands, they activate both the innate and adaptive immunity (3). TLR4, the fi rst mammalian TLR identifi ed, recognizes the cell wall of Gram-negative bacterial lipopolysaccharide (LPS) (4) .
It has been demonstrated that upon infection, LPS induced up-regulation of TLR4. The TLR4 pathway signalling leads to an increased myeloid differentiation primary-response gene 88 (MyD88 ) activation, which enhances the translocation of NF-κB to the nucleus, subsequently NF-κB binds to target genes promoter and leads to tumour genesis (5) (6) (7) .
Recent fi ndings showed that functional TLRs are expressed not only on immune cells, but also on cancer cells. TLR4 activation upon chronic infection has been accepted as one of the leading cause of infl ammation -induced cancer. Thus, infection is a major cause of human cancer in up to one-fi fth of all cases (8, 9) . It also enhances cancer metastasis (10) .
Cancer cells show different behaviours in their signalling from each other, some studies showed that activated TLR4 signalling pathway plays proliferative and anti-apoptotic roles in cancer cells, however, the results are inconclusive (11) .
Mouse melanoma (B16F10) and mouse breast cancer (4T1) cell lines are widely used as a model for studying many aspects of cancer biology, which can be extrapolated to human malignancies (12, 13) .
Objectives
The aim of this study was to investigate the effect of ultra-pure LPS, a specifi c TLR4 ligand, on signal transduction pathway of these two mouse cancer cell lines.
Materials and Methods

Cells and Reagents
The mouse melanoma cell line (B16F10) and mouse breast cancer cell line (4T1) were obtained from the National Cell bank of Iran (affi liated to Pasteur Institute, Tehran, Iran). The B16F10 cells were cultured in Dulbecco's Modifi ed Eagle's medium (DMEM) and the 4T cells were cultured in RPMI (Roswell Park Memorial Institute) 1640 medium in a humidifi ed atmosphere of 5 % CO 2 . All media were supplemented with 10 % foetal bovine serum (FBS), HEPES, and penicillin/streptomycin. All cell culture materials were from Gibco, USA. LPS-EB ultrapure that is lipopolysaccharide from E. coli 0111:B4 was purchased from Invivogen (San Diego, CA).
Cell proliferation
The proliferation of B16F10 and 4T1 cells was evaluated by seeding 8×10 3 cells/well in 96 well, fl at-bottoms, microtiter plates. Cell growth in the presence or absence of ultra-pure LPS (0, 1.25, 2.5, 5, 7.5, 10 μg/ml) (7, 14) was measured after 4, 16, 24, 48 h treatment. The fi nal volume of complete culture medium was 200 μl.
The metabolic activity in each well was determined by 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyl-2H-tetrazolium bromide (MTT) assay and compared to the untreated cells. Plates were read by using an enzyme-linked immunosorbent assay (ELISA) plate reader (ELX 800-BioTek-USA) at 570 nm with a reference wavelength of 630 nm (15) . The cell viability was determined by the following formula: % Cell viability = (Mean absorbance in test wells/Mean absorbance in control wells) × 100
Quantitative real-time reverse transcriptase-polymerase chain reaction (QRT-PCR)
Since LPS-EB Ultrapure is a specifi c TLR4 agonist, we used it in this study to activate the TLR4 signalling .The cells were stimulated 24 h with or without of LPS (5 μg/ml). Total cellular RNA was extracted GeneJET RNA purifi cation kit (Thermo Scientifi c, (EU) Lithuania). One microgram of total RNA was utilized for the reverse transcriptase reaction. cDNA was synthesized using RevertAidTM Reverse Transcriptase (Fermentas, Vilnius, Lithuania) with oligo-dT primers.
The PCR assay began with one cycle of denaturation at 95°C for 5 min, followed by 45 cycles of 95°C for 1 min, 1-min annealing period of 54°C for TLR4, MyD88, NF-κB and beta actin (as internal control). A second 1-min annealing period was completed at 72°C before a fi nal extension at 72°C for 10 min.
RT-PCR analyses were performed using the following primer sets:
MyD88:
Forward primer) 5′-TGT TAC CAA CTG GGA CGA CAT GGA 3′( Reverse primer) 5′-CCG CTC GTT GCC AAT AGT GAT GAC -3′(
The qRT-PCR cDNA products were verifi ed using a 2 % agarose gel. (The quality of RNA was verifi ed by spectrophotometer and gel electrophoresis.)
Quantitative RT-PCR was performed using specifi c primers for TLR4, MyD88 , NF-κB and beta-actin (as an internal control) mRNAs with the Maxima SYBR Green/ROX qPCR Master Mix (Fermentas, Vilnius, Lithuania) and run on the Rotor-gene 6000(Qiagen, Hilden, Germany). 
Statistical analysis
The experiments were performed in triplicate and replicated two times. At last, one-way analysis of variance (ANOVA) and t-test analysis was performed to analyse the data using the software SPSS 20. Values of p < 0.05 were considered statistically signifi cant.
Results
Effect of lipopolysaccharide on B16F10 and 4T1 cell lines viability
The MTT assay was used to determine the effects of TLR4 stimulation on B16F10 and 4T1 cell proliferation. The cells were exposed to culture medium or ultra-pure LPS (0, 1.25, 2.5, 5, 7.5, 10 μg/ml) for 4, 16, 24 and 48 h.
LPS did not infl uence the proliferation rate in B16F10 cell line tested after 4, 16 and 48 h (p > 0.05) (Fig. 1) . After 24 hours of incubation, only LPS in 5 μg/ml dose signifi cantly increased B16F10 cell viability (p < 0.005) (Fig. 1) . LPS did not signifi cantly affect the proliferation rate of 4T1 cells under different LPS-treated conditions (p > 0.05).
LPS up regulates the expression of TLR4, MyD88 and NF-κB in B16F10 and 4T1 cell lines
Because LPS at concentration of 5μg/ml signifi cantly increased the cell viability, we chose this concentration for mRNA expression test. As shown in Figure 2 , the expression of TLR4 mRNA in melanoma and 4T1 cell line was analysed by qRT-PCR. TLR4 mRNA expression was signifi cantly up-regulated in B16F10 (p = 0.003) and 4T1 cells (p = 0.022) 24 h after stimulation.
To investigate the downstream molecular events of LPS-TLR4 signalling in these cells, we examined the effect of LPS on the MyD88 mRNA expression. MyD88 mRNA expression was significantly up regulated in both B16F10 (p = 0.005) and 4T1cells (p = 0.033), following LPS treatment. Although the mRNA expression of NF-κB was signifi cantly enhanced in B16F10 (p = 0.031 and 4T1 (p < 0.001).
Discussion
In this study, we tried to evaluate the effects of different concentrations of ultra-pure LPS (0, 1.25, 2.5, 5, 7.5, 10 μg/ml) in different times (4, 16, 24 , 48 h) on the cell viability of B16F10 and 4T1 cell lines and their TLR4 signal transduction pathway.
Results indicated that LPS at the concentration of 5 μg/ml signifi cantly increased proliferation in B16F10 cell after 24 hours. However, other doses and times, LPS did not signifi cantly altered melanoma cell viability.
LPS treatment in 4T1 cell increased the cell viability compared to the control after treatment, but results were not signifi cant. Overall, the results indicated that LPS has a distinct effect on cell proliferation and viability depending on the time, concentration and type of cell used.
For example, LPS did not infl uence the proliferation rate in any of melanoma cell lines tested such as SKMEL-28, BN1, 9923P, 9923M cell lines, while the other studies showed that LPS promoted proliferation of TLR4 + melanoma cells (14) . In the other study, knockdown of TLR4 in human breast cancer cell line (MDA-MB-231) signifi cantly reduced proliferation and survival of tumour cell proliferation (16) . This is true for the other cancer cell lines such as human oesophageal and oral cancer cells (17) . This is the fi rst study to our knowledge that examines the effect of ultra-pure LPS on mouse melanoma cell line (B16F10) and mouse breast cancer cell line (4T1) proliferation.
The link between TLR signalling and cell cycle control has not been explored yet (18, 19) . Activation of TLR4 might be related to tumour growth as it regulates the expression of vascular endothelial growth factor (VEGF) mRNA in human breast cancer cells. The stimulation of TLR4 by LPS promotes tumour genesis and the development of metastatic lesions in the liver of mice (20).
Pidgeon et al showed that during tumour surgery, when LPS is introduced in mice, quickly prompted infl ammatory reactions in immune system and tumour metastasis increased (10). To better understand the mechanisms involved in LPS effects, we compared TLR4, MyD88 and NF-κB gene expression with or without LPS treatment. Because LPS at concentration of 5 μg/ml signifi cantly increased the cell viability, we chose this concentration for mRNA expression test.
The results of qRT-PCR assay showed that B16F10 and 4T1 cell lines expressed TLR4, MyD88 and Nf-κB signifi cantly more than the control.
LPS binding to TLR4 activates MyD88-dependent signalling. Internalization of the LPS-TLR4 complex activates TIR-domaincontaining adaptor protein inducing IFNβ (TRIF)-mediated signalling (MyD88-independent signalling) in the endosome (21, 22).
MyD88-defi cient mice were shown to be resistant to LPS-induced septic shock, and MyD88-defi cient macrophages failed to produce proinfl ammatory cytokines after LPS stimulation, despite the ability to activate NF-κB (23).
NF-κB signalling promotes infl ammation and cell proliferation through induction of infl ammatory cytokines and inhibition on both death receptor pathway of apoptosis and mitochondrial pathway of apoptosis (24).
In this study, stimulation of TLR4 by specifi c agonist, ultrapure LPS increased NF-κB expression.
In conclusion, the present study provides evidence that LPS can stimulate TLR4 signalling in both mouse cancer cell lines. It should be concluded that B16F10 and 4T1 could be used as a good model for in vitro and in vivo TLR4 signalling research.
